Angiocentric T-cell lymphoma associated with diabetes insipidus.
Ramsahoye
B H
BH
Griffiths
D F
DF
Whittaker
J A
JA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001158:Arteries / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology; D003630:Daunorubicin / Q000008:administration & dosage; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000473:pathology; D010904:Pituitary Gland, Posterior / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage; D013894:Thirst; D019043:Vascular Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D011239:Prednisolone; D003894:Deamino Arginine Vasopressin; D003630:Daunorubicin